Skip to main content

IPHA · Innate Pharma SA · Documents

Track IPHA — free
$1.39 +0.06 (+4.51%) Play latest call Q2 2026 earnings call transcript
Market Cap
$148.56M
Shares
111.70M
Volume · Nov 4 10.67K Avg daily vol (3M) 158.14K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2021
Apr 27
Annual report 20-F FY2020, ended Dec 31
Annual report for FY2020
Revenue 70.45M EUR ▼ 17.9% Net loss 63.98M EUR Diluted EPS -0.81 EUR
2020
Apr 24
Annual report 20-F FY2019, ended Dec 31
Annual report for FY2019
Revenue 85.81M EUR ▼ 8.7% Net loss 20.76M EUR Diluted EPS -0.31 EUR
Showing 251–300 of 307 documents
Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 4 filings 4 filers Visit website Investor relations